180 related articles for article (PubMed ID: 31711694)
1. Treatment of experimentally induced benign prostatic hyperplasia with Tadalafil and castration in dogs.
Dearakhshandeh N; Mogheiseh A; Nazifi S; Ahrari Khafi MS; Abbaszadeh Hasiri M; Golchin-Rad K
Theriogenology; 2020 Jan; 142():236-245. PubMed ID: 31711694
[TBL] [Abstract][Full Text] [Related]
2. Changes in the Serum Prostatic Biomarkers During the Treatment of Benign Prostatic Hyperplasia with a 5alpha-reductase Inhibitor: Finasteride.
Golchin-Rad K; Mogheiseh A; Nazifi S; Ahrari Khafi MS; Derakhshandeh N; Abbaszadeh-Hasiri M
Top Companion Anim Med; 2020 Mar; 38():100405. PubMed ID: 32115076
[TBL] [Abstract][Full Text] [Related]
3. Changes in the oxidative stress factors and inflammatory proteins following the treatment of BPH-induced dogs with an anti-proliferative agent called tadalafil.
Dearakhshandeh N; Mogheiseh A; Nazifi S; Ahrari Khafi MS; Abbaszadeh Hasiri M; Golchin-Rad K
J Vet Pharmacol Ther; 2019 Nov; 42(6):665-672. PubMed ID: 31410874
[TBL] [Abstract][Full Text] [Related]
4. The association between the serum concentration of canine prostate specific esterase (CPSE) and the size of the canine prostate.
Holst BS; Holmroos E; Friling L; Hanås S; Langborg LM; Franko MA; Hansson K
Theriogenology; 2017 Apr; 93():33-39. PubMed ID: 28257864
[TBL] [Abstract][Full Text] [Related]
5. Echotexture Analysis of Prostate Parenchyma for Detection of Benign Prostatic Hyperplasia in Dogs.
Khanbazi MH; Mogheiseh A; Ahrari Khafi MS; Nazifi S; Derakhshandeh N; Golchin-Rad K
Top Companion Anim Med; 2021 Mar; 42():100501. PubMed ID: 33249242
[TBL] [Abstract][Full Text] [Related]
6. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of serum and seminal plasma markers in the diagnosis of canine prostatic disorders.
Bell FW; Klausner JS; Hayden DW; Lund EM; Liebenstein BB; Feeney DA; Johnston SD; Shivers JL; Ewing CM; Isaacs WB
J Vet Intern Med; 1995; 9(3):149-53. PubMed ID: 7545754
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of biomarker canine-prostate specific arginine esterase (CPSE) for the diagnosis of benign prostatic hyperplasia.
Pinheiro D; Machado J; Viegas C; Baptista C; Bastos E; Magalhães J; Pires MA; Cardoso L; Martins-Bessa A
BMC Vet Res; 2017 Mar; 13(1):76. PubMed ID: 28335775
[TBL] [Abstract][Full Text] [Related]
9. Changes in specific serum biomarkers during the induction of prostatic hyperplasia in dogs.
Golchin-Rad K; Mogheiseh A; Nazifi S; Ahrari Khafi MS; Derakhshandeh N; Abbaszadeh-Hasiri M
BMC Vet Res; 2019 Dec; 15(1):440. PubMed ID: 31805935
[TBL] [Abstract][Full Text] [Related]
10. Canine Prostate Disease.
Christensen BW
Vet Clin North Am Small Anim Pract; 2018 Jul; 48(4):701-719. PubMed ID: 29933768
[TBL] [Abstract][Full Text] [Related]
11. Perfusion change in benign prostatic hyperplasia before and after castration in a canine model: Contrast enhanced ultrasonography and CT perfusion study.
Yoon S; Alfajaro MM; Cho KO; Choi US; Je H; Jung J; Jang Y; Choi J
Theriogenology; 2020 Oct; 156():97-106. PubMed ID: 32682181
[TBL] [Abstract][Full Text] [Related]
12. Effects of benign prostatic hyperplasia and finasteride therapy on prostatic blood flow in dogs.
Angrimani DSR; Silvestrini GR; Brito MM; Abreu RA; Almeida LL; Vannucchi CI
Theriogenology; 2018 Jul; 114():103-108. PubMed ID: 29605575
[TBL] [Abstract][Full Text] [Related]
13. [Experimental research on spontaneous benign prostatic hyperplasia in old dogs].
Cai RF; Cui YG; Hua LX; Jia Y; Ma DZ; Wang XH
Zhonghua Nan Ke Xue; 2003 Dec; 9(9):651-3, 657. PubMed ID: 14727348
[TBL] [Abstract][Full Text] [Related]
14. Effects of a new steroidal aromatase inhibitor, TZA-2237, and/or chlormadinone acetate on hormone-induced and spontaneous canine benign prostatic hyperplasia.
Ito K; Fukabori Y; Shibata Y; Suzuki K; Mieda M; Gotanda K; Honma S; Yamanaka H
Eur J Endocrinol; 2000 Oct; 143(4):543-54. PubMed ID: 11022202
[TBL] [Abstract][Full Text] [Related]
15. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
16. Effect of the GnRH stimulation test on Canine Prostatic-Specific Esterase (CPSE).
Ferré-Dolcet L; Pisu MC; Attard S; Romagnoli S
Reprod Domest Anim; 2023 Aug; 58(8):1125-1131. PubMed ID: 37337834
[TBL] [Abstract][Full Text] [Related]
17. Testicular steroids, prolactin, relaxin and prostate gland markers in peripheral blood and seminal plasma of normal dogs and dogs with prostatic hyperplasia.
Wolf K; Kayacelebi H; Urhausen C; Piechotta M; Mischke R; Kramer S; Einspanier A; Oei CH; Günzel-Apel A
Reprod Domest Anim; 2012 Dec; 47 Suppl 6():243-6. PubMed ID: 23279510
[TBL] [Abstract][Full Text] [Related]
18. Post-castration prostatic involution: A morphometric and endocrine study of healthy canines and those with benign prostatic hyperplasia.
Cazzuli G; Damián JP; Molina E; Pessina P
Reprod Domest Anim; 2022 Feb; 57(2):157-164. PubMed ID: 34724270
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of Tripterygium wilfordii multiglycoside on benign prostatic hyperplasia in rats.
Shen HN; Xu Y; Jiang ZZ; Huang X; Zhang LY; Wang T
Chin J Nat Med; 2015 Jun; 13(6):421-7. PubMed ID: 26073338
[TBL] [Abstract][Full Text] [Related]
20. Endocrine, prostatic vascular, and proapoptotic changes in dogs with benign prostatic hyperplasia treated medically or surgically.
Lima CB; Angrimani DSR; Flores RB; Vannucchi CI
Domest Anim Endocrinol; 2021 Apr; 75():106601. PubMed ID: 33333452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]